INMD - InMode: Phenomenal Growth And Margins But Its Revenue Growth Is Decelerating
- InMode Ltd. is a global healthcare company that develops its own radio-frequency-based devices for aesthetic and medical treatments.
- As part of its business strategy, INMD has achieved an 85% gross margin continuously for the past 6 years.
- INMD reported stunning revenue growth in 2021, due to pent-up demand resulting from the lockdowns.
- INMD is expanding its offerings beyond elective aesthetic treatments, to treat a myriad of medical conditions with its technology.
- We discuss whether INMD stock is still a buy now for investors.
For further details see:
InMode: Phenomenal Growth And Margins, But Its Revenue Growth Is Decelerating